Proteomics International Laboratories Past Earnings Performance
Past criteria checks 0/6
Proteomics International Laboratories's earnings have been declining at an average annual rate of -28.9%, while the Life Sciences industry saw earnings growing at 16.5% annually. Revenues have been growing at an average rate of 5.3% per year.
Key information
-28.9%
Earnings growth rate
-21.7%
EPS growth rate
| Life Sciences Industry Growth | 19.7% |
| Revenue growth rate | 5.3% |
| Return on equity | -70.1% |
| Net Margin | -194.6% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Proteomics International Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 3 | -6 | 7 | 0 |
| 31 Mar 24 | 3 | -6 | 6 | 0 |
| 31 Dec 23 | 3 | -6 | 6 | 0 |
| 30 Sep 23 | 3 | -6 | 6 | 0 |
| 30 Jun 23 | 3 | -6 | 6 | 0 |
| 31 Mar 23 | 3 | -6 | 6 | 0 |
| 31 Dec 22 | 4 | -6 | 6 | 0 |
| 30 Sep 22 | 3 | -5 | 6 | 0 |
| 30 Jun 22 | 3 | -5 | 5 | 0 |
| 31 Mar 22 | 3 | -5 | 5 | 0 |
| 31 Dec 21 | 3 | -4 | 5 | 0 |
| 30 Sep 21 | 3 | -4 | 4 | 0 |
| 30 Jun 21 | 3 | -3 | 4 | 0 |
| 31 Mar 21 | 3 | -3 | 4 | 0 |
| 31 Dec 20 | 2 | -2 | 4 | 0 |
| 30 Sep 20 | 3 | -2 | 3 | 0 |
| 30 Jun 20 | 3 | -2 | 3 | 0 |
| 31 Mar 20 | 3 | -2 | 3 | 0 |
| 31 Dec 19 | 3 | -2 | 2 | 1 |
| 30 Sep 19 | 3 | -2 | 3 | 1 |
| 30 Jun 19 | 3 | -2 | 3 | 1 |
| 31 Mar 19 | 3 | -2 | 3 | 1 |
| 31 Dec 18 | 3 | -2 | 3 | 0 |
| 30 Sep 18 | 2 | -2 | 2 | 0 |
| 30 Jun 18 | 2 | -1 | 2 | 0 |
| 31 Mar 18 | 2 | -1 | 2 | 0 |
| 31 Dec 17 | 2 | -1 | 2 | 0 |
| 30 Sep 17 | 2 | -1 | 2 | 0 |
| 30 Jun 17 | 2 | -1 | 2 | 0 |
| 31 Mar 17 | 2 | -1 | 2 | 0 |
| 31 Dec 16 | 2 | -1 | 2 | 0 |
| 30 Sep 16 | 2 | -1 | 2 | 0 |
| 30 Jun 16 | 1 | -1 | 2 | 0 |
| 31 Mar 16 | 1 | -2 | 2 | 0 |
| 31 Dec 15 | 1 | -2 | 2 | 0 |
| 30 Sep 15 | 1 | -2 | 1 | 0 |
| 30 Jun 15 | 1 | -1 | 1 | 0 |
| 30 Jun 14 | 1 | 0 | 1 | 0 |
Quality Earnings: PIQ is currently unprofitable.
Growing Profit Margin: PIQ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PIQ is unprofitable, and losses have increased over the past 5 years at a rate of 28.9% per year.
Accelerating Growth: Unable to compare PIQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PIQ is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-4.7%).
Return on Equity
High ROE: PIQ has a negative Return on Equity (-70.08%), as it is currently unprofitable.